13F Portfolios

Irenic Capital Management LP — DIEBOLD NIXDORF INC DBD: Quarterly 13F Position History

Irenic Capital Management LP has reported DIEBOLD NIXDORF INC (DBD) on 11 13F-HR filings in Pactolio's tracked window, first appearing in Q3 2023. As of Q1 2026, the position is sized at 480,557 shares ($36.3M market value, 3.29% of the equity book). Quarter-over-quarter share count change: 163,500 (-25.4%) .

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 11 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 480,557 163,500 -25.4% $36.3M 3.29% $75.44
Q4 2025 644,057 +50,596 +8.5% $43.7M 5.73% $67.89
Q3 2025 593,461 1,762 -0.3% $33.8M 6.65% $57.03
Q2 2025 595,223 125,435 -17.4% $33.0M 7.25% $55.40
Q1 2025 720,658 +87,331 +13.8% $31.5M 4.78% $43.72
Q4 2024 633,327 +60,548 +10.6% $27.3M 4.15% $43.04
Q3 2024 572,779 +23,206 +4.2% $25.6M 4.49% $44.66
Q2 2024 549,573 +40,071 +7.9% $21.1M 5.13% $38.48
Q1 2024 509,502 +16,249 +3.3% $17.5M 4.49% $34.44
Q4 2023 493,253 +89,496 +22.2% $14.3M 3.09% $28.95
Q3 2023 403,757 $7.6M 2.34% $18.94

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Irenic Capital Management LP first disclose a DBD position in 13F-HR filings?

Irenic Capital Management LP first reported DIEBOLD NIXDORF INC (DBD) on its 13F-HR filing for the period ending 2023-09-30 (Q3 2023). The position has appeared on 11 reported quarters within Pactolio's tracked window.

What was Irenic Capital Management LP's most recent quarter-over-quarter share-count change in DBD?

Between Q4 2025 and Q1 2026, Irenic Capital Management LP reduced its DBD position by 163,500 shares (-25.4%), leaving 480,557 shares at a market value of $36.3M.

Does the implied price-per-share represent Irenic Capital Management LP's cost basis in DBD?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.